{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:47:59Z","timestamp":1793807279767,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.crmicr.2025.100395","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:04:12Z","timestamp":1745305452000},"page":"100395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Potency of all-D amino acid antimicrobial peptides derived from the bovine rumen microbiome on tuberculous and non-tuberculous mycobacteria"],"prefix":"10.1016","volume":"8","author":[{"given":"C\u00e9line","family":"Boidin-Wichlacz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Point","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Reinbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Huws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Tasiemski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Canaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-8314","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jac\/dku570","article-title":"Natural antimicrobial peptides against mycobacterium tuberculosis","volume":"70","author":"Abedinzadeh","year":"2015","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.crmicr.2025.100395_bib0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","article-title":"Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria","volume":"133","author":"Ageitos","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41522-024-00560-2","article-title":"Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii","volume":"10","author":"Alexander","year":"2024","journal-title":"NPJ. Biofilms. Microbiomes."},{"issue":"2","key":"10.1016\/j.crmicr.2025.100395_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0038-2016","article-title":"Mycobacterium marinum","volume":"5","author":"Aubry","year":"2017","journal-title":"Microbiol. Spectr."},{"issue":"Suppl 1","key":"10.1016\/j.crmicr.2025.100395_bib0005","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1111\/j.1365-2125.2001.00377.x","article-title":"The therapeutic monitoring of antimicrobial agents","volume":"52","author":"Begg","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.colsurfb.2013.06.025","article-title":"New insights into the pH-dependent interfacial adsorption of dog gastric lipase using the monolayer technique","volume":"111","author":"Benarouche","year":"2013","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antibiotics9010018","article-title":"Looking beyond typical treatments for atypical mycobacteria","volume":"9","author":"Bento","year":"2020","journal-title":"Antibiotics. (Basel)"},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0008","article-title":"M. tuberculosis infection of human iPSC-derived macrophages reveals complex membrane dynamics during xenophagy evasion","volume":"134","author":"Bernard","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.crmicr.2025.100395_bib0009","series-title":"Mycobacteria Protocols","first-page":"257","article-title":"Antimicrobial susceptibility testing for mycobacterium sp","author":"Blanco-Ruano","year":"2015"},{"issue":"25","key":"10.1016\/j.crmicr.2025.100395_bib0010","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1021\/la301135z","article-title":"Influence of the physical state of phospholipid monolayers on protein binding","volume":"28","author":"Boisselier","year":"2012","journal-title":"Langmuir."},{"issue":"4","key":"10.1016\/j.crmicr.2025.100395_bib0011","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cbpa.2011.05.023","article-title":"High-content screening in infectious diseases","volume":"15","author":"Brodin","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100395_bib0012","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/antibiotics11101322","article-title":"Alternatives to antibiotics against mycobacterium abscessus","volume":"11","author":"Broncano-Lavado","year":"2022","journal-title":"Antibiotics. (Basel)"},{"issue":"6","key":"10.1016\/j.crmicr.2025.100395_bib0013","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biochi.2009.03.018","article-title":"Parameters modulating the maximum insertion pressure of proteins and peptides in lipid monolayers","volume":"91","author":"Calvez","year":"2009","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.crmicr.2025.100395_bib0014","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/la104097n","article-title":"Analysis of the contribution of saturated and polyunsaturated phospholipid monolayers to the binding of proteins","volume":"27","author":"Calvez","year":"2011","journal-title":"Langmuir."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100395_bib0015","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JCM.00549-14","article-title":"Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients","volume":"52","author":"Candido","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-024-01007-8","article-title":"Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen mycobacterium abscessus","volume":"31","author":"Casanova","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0017","first-page":"12","article-title":"Evaluation of the efficiency of random and diblock methacrylate-based amphiphilic cationic polymers against major bacterial pathogens associated with cystic fibrosis","author":"Casanova","year":"2023","journal-title":"Antibiotics. (Basel)"},{"issue":"2","key":"10.1016\/j.crmicr.2025.100395_bib0018","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/IAI.00835-06","article-title":"Hypervirulence of a rough variant of the mycobacterium abscessus type strain","volume":"75","author":"Catherinot","year":"2007","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0019","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/JCM.01478-08","article-title":"Acute respiratory failure involving an R variant of mycobacterium abscessus","volume":"47","author":"Catherinot","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0020","article-title":"Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100395_bib0021","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.4155\/fmc.10.223","article-title":"High-content imaging of mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery","volume":"2","author":"Christophe","year":"2010","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100395_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2\u2032 epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog."},{"issue":"5\u20136","key":"10.1016\/j.crmicr.2025.100395_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.resmic.2020.03.001","article-title":"Antimicrobial peptides against drug resistant mycobacterium abscessus","volume":"171","author":"da Silva","year":"2020","journal-title":"Res. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0024","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","article-title":"Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease","volume":"23","author":"Dartois","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.crmicr.2025.100395_bib0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/978-1-0716-1460-0_29","article-title":"High-content analysis monitoring intracellular trafficking and replication of mycobacterium tuberculosis inside host cells","volume":"2314","author":"Deboosere","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tube.2016.07.011","article-title":"Micrococcin P1 - a bactericidal thiopeptide active against mycobacterium tuberculosis","volume":"100","author":"Degiacomi","year":"2016","journal-title":"Tuberculosis. (Edinb)"},{"issue":"8","key":"10.1016\/j.crmicr.2025.100395_bib0027","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/jm200076a","article-title":"Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors","volume":"54","author":"Flipo","year":"2011","journal-title":"J. Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.crmicr.2025.100395_bib0028","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax."},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01276-18","article-title":"Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of mycobacterium tuberculosis","volume":"9","author":"Foo","year":"2018","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.crmicr.2025.100395_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","article-title":"Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2","volume":"21","author":"Gavrish","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0031","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c00702","article-title":"Advantages and challenges of using antimicrobial peptides in synergism with antibiotics for treating multidrug-resistant bacteria","author":"Gon\u00e7alves","year":"2025","journal-title":"ACS. Infect. Dis."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100395_bib0032","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1021\/bi00838a031","article-title":"Computed circular dichroism spectra for the evaluation of protein conformation","volume":"8","author":"Greenfield","year":"1969","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.crmicr.2025.100395_bib0033","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.crmicr.2025.100395_bib0034","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.crmicr.2025.100395_bib0035","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.crmicr.2025.100395_bib0036","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ja01080a015","article-title":"The ultraviolet circular dichroism of polypeptides","volume":"87","author":"Holzwarth","year":"1965","journal-title":"J. Am. Chem. Soc."},{"issue":"27","key":"10.1016\/j.crmicr.2025.100395_bib0037","doi-asserted-by":"crossref","first-page":"23967","DOI":"10.1021\/acsomega.2c02844","article-title":"High-throughput screening identifies synthetic peptides with antibacterial activity against mycobacterium abscessus and serum stability","volume":"7","author":"Iannuzo","year":"2022","journal-title":"ACS. Omega"},{"key":"10.1016\/j.crmicr.2025.100395_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194923","article-title":"Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible?","volume":"14","author":"Jacobo-Delgado","year":"2023","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.crmicr.2025.100395_bib0039","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/cbic.202100151","article-title":"Molecular basis of selectivity and activity for the antimicrobial peptide Lynronne-1 informs rational design of peptide with improved activity","volume":"22","author":"Jayawant","year":"2021","journal-title":"Chembiochem."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100395_bib0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/abbs\/gmx091","article-title":"D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP","volume":"49","author":"Jia","year":"2017","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"7","key":"10.1016\/j.crmicr.2025.100395_bib0041","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.crmicr.2025.100395_bib0042","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.tube.2014.08.001","article-title":"Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant mycobacterium tuberculosis","volume":"94","author":"Lan","year":"2014","journal-title":"Tuberculosis. (Edinb)"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0043","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0033-1333574","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"34","author":"Leung","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"Pt 3","key":"10.1016\/j.crmicr.2025.100395_bib0044","article-title":"Antibacterial peptide RP557 increases the antibiotic sensitivity of mycobacterium abscessus by inhibiting biofilm formation","volume":"807","author":"Li","year":"2022","journal-title":"Sci. Total. Environ."},{"issue":"25","key":"10.1016\/j.crmicr.2025.100395_bib0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202295119","article-title":"Membrane insertion mechanism of the caveola coat protein Cavin1","volume":"119","author":"Liu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.crmicr.2025.100395_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/fermentation10110540","article-title":"A review of antimicrobial peptides: structure, mechanism of action, and molecular optimization strategies","volume":"10","author":"Ma","year":"2024","journal-title":"Fermentation"},{"issue":"9","key":"10.1016\/j.crmicr.2025.100395_bib0047","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/acsinfecdis.9b00172","article-title":"Cyclipostins and cyclophostin analogues as multitarget inhibitors that impair growth of mycobacterium abscessus","volume":"5","author":"Madani","year":"2019","journal-title":"ACS. Infect. Dis."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100395_bib0048","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-4157(96)00009-3","article-title":"Lateral pressure in membranes","volume":"1286","author":"Marsh","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0049","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10989-022-10435-9","article-title":"Role of antimicrobial peptides in treatment and prevention of mycobacterium tuberculosis: a review","volume":"28","author":"Mehta","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"Suppl 1","key":"10.1016\/j.crmicr.2025.100395_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S1751731112000419","article-title":"Rumen microbial (meta)genomics and its application to ruminant production","volume":"7","author":"Morgavi","year":"2013","journal-title":"Animal."},{"issue":"9","key":"10.1016\/j.crmicr.2025.100395_bib0051","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmi.2023.07.013","article-title":"Recent advances in the treatment of tuberculosis","volume":"30","author":"Motta","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0052","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41522-022-00332-w","article-title":"Microbiome-derived antimicrobial peptides offer therapeutic solutions for the treatment of Pseudomonas aeruginosa infections","volume":"8","author":"Mulkern","year":"2022","journal-title":"NPJ. Biofilms. Microbiomes."},{"issue":"4","key":"10.1016\/j.crmicr.2025.100395_bib0053","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.crmicr.2025.100395_bib0054","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bioorg.2018.08.025","article-title":"Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis","volume":"81","author":"Nguyen","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11843-4","article-title":"Cyclipostins and cyclophostin analogs as promising compounds in the fight against tuberculosis","volume":"7","author":"Nguyen","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0056","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12866-021-02172-8","article-title":"The rumen eukaryotome is a source of novel antimicrobial peptides with therapeutic potential","volume":"21","author":"Onime","year":"2021","journal-title":"BMC. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0057","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41522-017-0042-1","article-title":"The rumen microbiome: an underexplored resource for novel antimicrobial discovery","volume":"3","author":"Oyama","year":"2017","journal-title":"NPJ. Biofilms. Microbiomes."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0058","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41522-022-00320-0","article-title":"In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus","volume":"8","author":"Oyama","year":"2022","journal-title":"NPJ. Biofilms. Microbiomes."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100395_bib0059","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100395_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes of lung disease caused by mycobacterium abscessus and mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.crmicr.2025.100395_bib0061","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.crmicr.2025.100395_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/srep29297","article-title":"STAT3 Represses nitric oxide synthesis in Human macrophages upon Mycobacterium tuberculosis infection","volume":"6","author":"Queval","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0063","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41598-021-83755-3","article-title":"A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy","volume":"11","author":"Rao","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0064","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.3390\/ijms24054635","article-title":"Mycobacterium abscessus infections in cystic fibrosis individuals: a review on therapeutic options","volume":"24","author":"Recchia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.crmicr.2025.100395_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"32","key":"10.1016\/j.crmicr.2025.100395_bib0066","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.2004045117","article-title":"The unusual structure of ruminococcin C1 antimicrobial peptide confers clinical properties","volume":"117","author":"Roblin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"37\u201339","key":"10.1016\/j.crmicr.2025.100395_bib0067","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.crmicr.2025.100395_bib0068","doi-asserted-by":"crossref","DOI":"10.3390\/biology10020096","article-title":"Drug resistance in nontuberculous mycobacteria: mechanisms and models","volume":"10","author":"Saxena","year":"2021","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.crmicr.2025.100395_bib0069","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD approach for peptide and miniprotein structure prediction","volume":"10","author":"Shen","year":"2014","journal-title":"J. Chem. Theory. Comput."},{"key":"10.1016\/j.crmicr.2025.100395_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.crmicr.2025.100395_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260003","article-title":"Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant mycobacterium abscessus","volume":"16","author":"Sudadech","year":"2021","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.crmicr.2025.100395_bib0072","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00228-015-1832-0","article-title":"Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide","volume":"71","author":"Tamargo","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0073","doi-asserted-by":"crossref","first-page":"W288","DOI":"10.1093\/nar\/gks419","article-title":"PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides","volume":"40","author":"Thevenet","year":"2012","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0074","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abio.1993.1450","article-title":"Circular dichroic analysis of denatured proteins: inclusion of denatured proteins in the reference set","volume":"214","author":"Venyaminov","year":"1993","journal-title":"Anal. Biochem."},{"issue":"Web Server issue","key":"10.1016\/j.crmicr.2025.100395_bib0075","doi-asserted-by":"crossref","first-page":"W668","DOI":"10.1093\/nar\/gkh371","article-title":"DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data","volume":"32","author":"Whitmore","year":"2004","journal-title":"Nucleic. Acids. Res."},{"issue":"1\u20132","key":"10.1016\/j.crmicr.2025.100395_bib0078","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00232-011-9343-0","article-title":"Antimicrobial peptides: successes, challenges and unanswered questions","volume":"239","author":"Wimley","year":"2011","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0079","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"Woods","year":"2011"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100395_bib0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.0403147","article-title":"Cathelicidins, multifunctional peptides of the innate immunity","volume":"75","author":"Zanetti","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.crmicr.2025.100395_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102266","article-title":"Spatiotemporal perspectives on tuberculosis chemotherapy","volume":"72","author":"Zhu","year":"2023","journal-title":"Curr. Opin. Microbiol."}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517425000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517425000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:23:46Z","timestamp":1749522226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517425000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":79,"alternative-id":["S2666517425000574"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100395","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potency of all-D amino acid antimicrobial peptides derived from the bovine rumen microbiome on tuberculous and non-tuberculous mycobacteria","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100395"}}